{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:04:56Z","timestamp":1792659896115,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.pan.2017.11.014","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T01:15:56Z","timestamp":1512522956000},"page":"94-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates"],"prefix":"10.1016","volume":"18","author":[{"given":"Thomas J.","family":"Vogl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz H.","family":"Albrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Gruber-Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour Eldin A.","family":"Nour Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iliana","family":"Bednarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagy N.","family":"Naguib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Panahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2017.11.014_bib1","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136.5","author":"Ferlay","year":"2015","journal-title":"Int J cancer"},{"key":"10.1016\/j.pan.2017.11.014_bib2","series-title":"Histological typing of tumours of the exocrine pancreas","author":"Kl\u00f6ppel","year":"1996"},{"key":"10.1016\/j.pan.2017.11.014_bib3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.dld.2015.11.001","article-title":"Prognostic and predictive markers in pancreatic adenocarcinoma","volume":"48.3","author":"Le","year":"2016","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.pan.2017.11.014_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejca.2015.12.026","article-title":"Current standards and new innovative approaches for treatment of pancreatic cancer","volume":"57","author":"Conroy","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pan.2017.11.014_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5009\/gnl.2010.4.3.384","article-title":"Transcatheter arterial chemoembolization for hepatic recurrence after curative resection of pancreatic adenocarcinoma","volume":"4.3","author":"Kim","year":"2010","journal-title":"Gut liver"},{"key":"10.1016\/j.pan.2017.11.014_bib6","first-page":"295","article-title":"Management of hepatic metastases of well\/moderately differentiated neuroendocrine tumors of the digestive tract","volume":"2","author":"La Salvia","year":"2016","journal-title":"J\u00a0Cancer Metastasis Treat"},{"key":"10.1016\/j.pan.2017.11.014_bib7","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1097\/MPA.0b013e318220e5b9","article-title":"Liver metastases of pancreatic cancer: role of repetitive transarterial chemoembolization (TACE) on tumor response and survival","volume":"40.8","author":"Azizi","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2017.11.014_bib8","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.1987.5.11.1836","article-title":"Tumor and liver drug uptake following hepatic artery and portal vein infusion","volume":"5.11","author":"Sigurdson","year":"1987","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.pan.2017.11.014_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jmri.22167","article-title":"Predicting and monitoring cancer treatment response with diffusion-weighted MRI","volume":"32.1","author":"Thoeny","year":"2010","journal-title":"J\u00a0Magn Reson Imaging"},{"key":"10.1016\/j.pan.2017.11.014_bib10","first-page":"611","article-title":"Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients","volume":"27.6","author":"Favelier","year":"2015","journal-title":"Chin J Cancer Res"},{"issue":"2","key":"10.1016\/j.pan.2017.11.014_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pan.2017.11.014_bib12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364.19","author":"Conroy","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.pan.2017.11.014_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00330-002-1558-0","article-title":"Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors","volume":"13.1","author":"Roche","year":"2003","journal-title":"Eur Radiol"},{"key":"10.1016\/j.pan.2017.11.014_bib14","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1148\/radiol.2392042202","article-title":"Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants\u2014initial experience","volume":"239.2","author":"Chen","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.pan.2017.11.014_bib15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.ejrad.2012.11.026","article-title":"Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization. Preliminary experience","volume":"82.4","author":"Mannelli","year":"2013","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.pan.2017.11.014_bib16","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ejrad.2009.05.040","article-title":"Role of magnetic resonance diffusion-weighted imaging in evaluating response after chemoembolization of hepatocellular carcinoma","volume":"75.1","author":"Yuan","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.pan.2017.11.014_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.RVI.0000200052.02183.92","article-title":"The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma","volume":"17.3","author":"Kamel","year":"2006","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.pan.2017.11.014_bib18","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.jvir.2008.05.002","article-title":"Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging","volume":"19.8","author":"Rhee","year":"2008","journal-title":"J\u00a0Vasc Intervent Radiol"},{"key":"10.1016\/j.pan.2017.11.014_bib19","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.acra.2007.10.022","article-title":"Diffusion-weighted MR: therapeutic evaluation after chemoembolization of VX-2 carcinoma implanted in rabbit liver","volume":"15.5","author":"Youn","year":"2008","journal-title":"Acad Radiol"},{"key":"10.1016\/j.pan.2017.11.014_bib20","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1148\/radiol.2502072222","article-title":"Unresectable hepatocellular carcinoma: serial early vascular and cellular changes after transarterial chemoembolization as detected with MR imaging","volume":"250.2","author":"Kamel","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.pan.2017.11.014_bib21","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.2214\/AJR.08.1461","article-title":"Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver","volume":"193.4","author":"Mannelli","year":"2009","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.pan.2017.11.014_bib22","doi-asserted-by":"crossref","first-page":"6794","DOI":"10.3748\/wjg.v21.i22.6794","article-title":"Prognostication and response assessment in liver and pancreatic tumors: the new imaging","volume":"21.22","author":"De Robertis","year":"2015","journal-title":"World J Gastroenterol WJG"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S142439031730889X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S142439031730889X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:06:59Z","timestamp":1761408419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S142439031730889X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S142439031730889X"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2017.11.014","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial chemoembolization in pancreatic adenocarcinoma with liver metastases: MR-based tumor response evaluation, apparent diffusion coefficient (ADC) patterns, and survival rates","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2017.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 IAP and EPC. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}